DK0675721T3 - Farmaceutiske præparater omfattende contignasterolforbindelser - Google Patents

Farmaceutiske præparater omfattende contignasterolforbindelser

Info

Publication number
DK0675721T3
DK0675721T3 DK94902581.1T DK94902581T DK0675721T3 DK 0675721 T3 DK0675721 T3 DK 0675721T3 DK 94902581 T DK94902581 T DK 94902581T DK 0675721 T3 DK0675721 T3 DK 0675721T3
Authority
DK
Denmark
Prior art keywords
compounds
pct
hydroxyl
contignasterol
pharmaceutical compositions
Prior art date
Application number
DK94902581.1T
Other languages
English (en)
Inventor
Raymond J Andersen
Theresa M Allen
David L Burgoyne
Original Assignee
Univ British Columbia
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ British Columbia, Univ Alberta filed Critical Univ British Columbia
Application granted granted Critical
Publication of DK0675721T3 publication Critical patent/DK0675721T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK94902581.1T 1992-12-23 1993-12-21 Farmaceutiske præparater omfattende contignasterolforbindelser DK0675721T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002086221A CA2086221C (en) 1992-12-23 1992-12-23 Contignasterol, and related 3-alpha hydroxy-6-alpha hydroxy-7-beta hydroxy-15-keto-14-beta steroids useful as anti-inflammatory and anti-thrombosis agent

Publications (1)

Publication Number Publication Date
DK0675721T3 true DK0675721T3 (da) 1998-04-06

Family

ID=4150905

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94902581.1T DK0675721T3 (da) 1992-12-23 1993-12-21 Farmaceutiske præparater omfattende contignasterolforbindelser

Country Status (11)

Country Link
US (1) US5646138A (da)
EP (1) EP0675721B1 (da)
JP (1) JP3366639B2 (da)
AT (1) ATE162946T1 (da)
AU (1) AU673405B2 (da)
CA (2) CA2086221C (da)
DE (1) DE69316927T2 (da)
DK (1) DK0675721T3 (da)
ES (1) ES2114678T3 (da)
GR (1) GR3026346T3 (da)
WO (1) WO1994014451A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100368425C (zh) * 1996-07-11 2008-02-13 茵弗莱采姆药物有限公司 6，7－氧化的甾族化合物及其用途
US6046185A (en) * 1996-07-11 2000-04-04 Inflazyme Pharmaceuticals Ltd. 6,7-oxygenated steroids and uses related thereto
EP1304333A3 (en) * 1996-07-11 2005-03-09 Inflazyme Pharmaceuticals, Ltd. 6,7-Oxygenated steroids and uses related thereto
US20040034216A1 (en) 2000-04-28 2004-02-19 Raymond Jeffrey R. 3-Nitrogen-6,7-dioxygen steroids and uses related thereto

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079239A (en) * 1990-02-16 1992-01-07 Harbor Branch Oceanographic Institution, Inc. Sterol disulfates and methods of use

Also Published As

Publication number Publication date
ES2114678T3 (es) 1998-06-01
DE69316927D1 (de) 1998-03-12
DE69316927T2 (de) 1998-10-22
GR3026346T3 (en) 1998-06-30
US5646138A (en) 1997-07-08
ATE162946T1 (de) 1998-02-15
CA2086221A1 (en) 1994-06-24
AU673405B2 (en) 1996-11-07
EP0675721B1 (en) 1998-02-04
CA2086221C (en) 2003-07-15
JPH08504773A (ja) 1996-05-21
CA2152621C (en) 2000-10-31
WO1994014451A1 (en) 1994-07-07
AU5691394A (en) 1994-07-19
CA2152621A1 (en) 1994-07-07
JP3366639B2 (ja) 2003-01-14
EP0675721A1 (en) 1995-10-11

Similar Documents

Publication Publication Date Title
HUP0300836A2 (hu) Taxánokat tartalmazó szájon át beadható gyógyszerkészítmények és ezek alkalmazása
HUP0103781A2 (hu) Megismerési képesség javítására szolgáló gyógyszerkészítmények, melyek atipikus antipszihotikus szer és acetilkolinészteráz inhibitor kombinációját tartalmazzák
DE69314779T2 (de) Prozess zur herstellung von beta-phenylisoserin und analogen verbindungen
FI955837A (fi) Menetelmä suun kautta annettavan, kiinteän, diklofenaakkia sisältävän annostelumuodon valmistamiseksi
DK0675721T3 (da) Farmaceutiske præparater omfattende contignasterolforbindelser
TW231970B (da)
ATE185071T1 (de) Steroide enthaltende zusammensetzungen zur anwendung am auge und ihre verwendung zur behandlung des glaukoms
ATE157010T1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
ATE216891T1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
ATE190484T1 (de) Arzneimittel zur behandlung von durch babesia verursachten protozoeninfektionen
EP0820771A3 (de) Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und eine Magnesiumverbindung enthält
FI950209A0 (fi) Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset
ATE190845T1 (de) Rektale flunisolid-zubereitung zur behandlung entzündlicher darmerkrankungen
ATE96319T1 (de) Glycyl-p-amino-pyridin zur behandlung von seniler demenz.
MY107023A (en) Antimalarial compositions